British Journal of Anaesthesia, 2003, Vol. 90, No. 5 617-622
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Target-controlled infusion of propofol and remifentanil in cardiac anaesthesia: influence of age on predicted effect-site concentrations
Institute of Cardiology, Department of Anaesthesia and Intensive Care, Pitié-Salpêtrière University Hospital, Paris, France
Presented in part at the 10th annual meeting of the European Society of Anaesthesiologists, Nice, France, April 6–9, 2002.
Background. Propofol-anaesthesia administrated via target-controlled infusion (TCI) has been proposed for cardiac surgery. Age-related changes in pharmacology explain why propofol dose requirement is reduced in elderly patients. However, the Marsh pharmacokinetic model incorporated in the Diprifusor propofol device does not take age into account as a covariable. In the absence of depth of anaesthesia monitoring, this limitation could cause adverse cardiovascular effects resulting from propofol overdose in older patients. We assessed the influence of age on effect-site propofol concentrations predicted by the Diprifusor and titrated to the bispectral index score (BIS) during cardiac anaesthesia.
Methods. Forty-five patients received propofol by Diprifusor and remifentanil by software including Minto model. Propofol and remifentanil effect-site concentrations were adapted to BIS (40–60) and haemodynamic profile, respectively. The influence of age on effect-site concentrations was assessed by dividing patients into two groups: young (<65 yr) and elderly (
65 yr).
Results. For a similar depth of anaesthesia, effect-site propofol concentrations were significantly lower in elderly patients at the different stages of cardiac surgery. The mean dose of propofol required to perform tracheal intubation was significantly lower in elderly patients. However, the overall doses of propofol were comparable in both groups. Neither effect-site remifentanil concentrations nor overall doses of remifentanil were significantly different between the two groups.
Conclusions. In cardiac anaesthesia, target concentrations of propofol must be reduced in elderly patients. Although this probably contributes to improving intraoperative haemodynamic stability, the absence of decrease in overall dose requirement of propofol suggests that this adjustment is relatively moderate.
Br J Anaesth 2003: 90: 617–22
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Steinlechner, M. Dworschak, B. Birkenberg, T. Lang, A. Schiferer, A. Moritz, B. Mora, and A. Rajek Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose-finding study Br. J. Anaesth., May 1, 2007; 98(5): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lecomte, A. Ouattara, Y. Le Manach, M. Landi, P. Coriat, and B. Riou The Coronary and Myocardial Effects of Remifentanil and Sufentanil in the Erythrocyte-Perfused Isolated Rabbit Heart. Anesth. Analg., July 1, 2006; 103(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|